- Home
- BMRN vs AUR Comparison
BMRN vs AUR Comparison
Compare BMRN & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- AUR
- Stock Information
- Founded
- BMRN 1996
- AUR 2017
- Country
- BMRN United States
- AUR United States
- Employees
- BMRN N/A
- AUR N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- AUR EDP Services
- Sector
- BMRN Health Care
- AUR Technology
- Exchange
- BMRN Nasdaq
- AUR Nasdaq
- Market Cap
- BMRN 10.0B
- AUR 9.9B
- IPO Year
- BMRN 1999
- AUR N/A
- Fundamental
- Price
- BMRN $52.47
- AUR $5.42
- Analyst Decision
- BMRN Buy
- AUR Buy
- Analyst Count
- BMRN 18
- AUR 9
- Target Price
- BMRN $93.71
- AUR $10.25
- AVG Volume (30 Days)
- BMRN 2.2M
- AUR 15.8M
- Earning Date
- BMRN 10-28-2025
- AUR 10-28-2025
- Dividend Yield
- BMRN N/A
- AUR N/A
- EPS Growth
- BMRN 154.69
- AUR N/A
- EPS
- BMRN 3.40
- AUR N/A
- Revenue
- BMRN $3,063,608,000.00
- AUR $1,000,000.00
- Revenue This Year
- BMRN $13.35
- AUR N/A
- Revenue Next Year
- BMRN $9.18
- AUR $855.12
- P/E Ratio
- BMRN $15.44
- AUR N/A
- Revenue Growth
- BMRN 18.36
- AUR N/A
- 52 Week Low
- BMRN $51.57
- AUR $4.75
- 52 Week High
- BMRN $73.51
- AUR $10.77
- Technical
- Relative Strength Index (RSI)
- BMRN 38.26
- AUR 45.07
- Support Level
- BMRN $51.79
- AUR $5.13
- Resistance Level
- BMRN $55.39
- AUR $5.66
- Average True Range (ATR)
- BMRN 1.36
- AUR 0.24
- MACD
- BMRN -0.11
- AUR -0.00
- Stochastic Oscillator
- BMRN 19.28
- AUR 50.88
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About AUR Aurora Innovation Inc.
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.